Precision Medicine in Neurodegenerative Disorders: Part II: Volume 193
★★★★★
★★★★★
English
Precision Medicine in Neurodegenerative Disorders, Part Two, Volume 193 in the Handbook of Clinical Neurology deals with the How in the reconfiguration of our approach to slow accelerated brain aging. The book rethinks animal models on which therapies are tested, outlines the progress and expected changes in biological subtyping efforts using lysosomal, endosomal, mitochondrial, immune dysregulation, and inflammatory mechanisms of disease pathophysiology, and the growing role of microbiome in shaping disease. The volume separates the potentially disease-modifying neurorescue and neurorestoration, (e.g., gene therapy and cell replacement therapy) from true precision medicinematching biology with the mechanism of intervention of interest. Specific chapters are dedicated to the promise and challenges of extracellular vesicles for both diagnosis and treatment, the growing application of digital measures and other evaluations of clinical response, the nuts and bolts of novel adaptive clinical trial designs, and the regulatory changes needed to facilitate drug development for disease-modification purposes.
See more
Current price
€217.54
Original price
€228.99
Save 5%
Delivery/Collection within 10-20 working days
Product Details
Dimensions: 195 x 260mm
Publication Date: 05 Jul 2023
Publisher: Elsevier - Health Sciences Division
Publication City/Country: United States
Language: English
ISBN13: 9780323855556
About
Dr. Alberto Espay is Professor and Endowed Chair of the James J. and Joan A. Gardner Center for Parkinsons disease at the University of Cincinnati. He has published over 300 peer-reviewed research articles and 8 books including Common Movement Disorders Pitfalls which received the Highly Commended BMA Medical Book Award in 2013 and Brain Fables the Hidden History of Neurodegenerative Diseases and a Blueprint to Conquer them coauthored with Parkinson patient and advocate Benjamin Stecher selected by the Association of American Publishers for the PROSE Award honoring the best scholarly work in Neuroscience published in 2020. He has served as Chair of the Movement Disorders Section of the American Academy of Neurology Associate Editor of the Movement Disorders journal and on the Executive Committee of the Parkinson Study Group. Among other honors he has received the Cincinnati Business Couriers Health Care Hero award the Spanish Society of Neurologys Cotzias award and honorary membership in the Mexican Academy of Neurology. He currently serves as President-Elect of the Pan-American Section of the International Parkinson and Movement Disorders Society. With colleagues at the University of Cincinnati he launched the first biomarker study of aging (CCBPstudy.com) designed to match people with neurodegenerative disorders to available therapies from which they are most biologically suitable to benefit regardless of their clinical diagnoses.